Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid vs Alendronate in Postmenopausal Osteoporosis
NCT00100555Phase 3Completed
- Sponsor
- Novartis
- Start
- Jun 2004
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zoledronic acid in postmenopausal osteoporosis, osteopenia, sponsored by Novartis. Started Jun 2004; status: completed.
02
Drugs
zoledronic acid
03
Conditions
postmenopausal osteoporosisosteopenia
Beyond the preview
Go deeper on NCT00100555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00100555.